Exubera and Revefenacin inhalation

• Generic Name: insulin inhalation, rapid acting
• Dosage Forms: inhalation powder
• Other Brand Names: Exubera, Afrezza, Exubera, EXUBERA Combination Pack 12, EXUBERA Combination Pack 15, EXUBERA Kit, Afrezza 4 unit- 8 unit, Afrezza 8 unit- 12 unit, Afrezza Titration Pack

Insulin inhalation (Exubera) was withdrawn from the U.S. market in 2007 due to lack of consumer demand for the product. No drug safety concerns were cited in this withdrawal.

Exubera is a rapid-acting form of human insulin that is inhaled through the mouth. It works by lowering levels of glucose (sugar) in the blood.

Exubera is used to treat type 1 (insulin dependent) or type 2 (non-insulin dependent) diabetes in adults.

• Generic Name: revefenacin
• Dosage Forms: n.a.
• Other Brand Names: Yupelri

Revefenacin is used to treat chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis.

Revefenacin relaxes the muscles in your lungs to help prevent wheezing, cough, chest tightness, and shortness of breath.

Revefenacin may also be used for purposes not listed in this medication guide.